Cellectar BioSciences News

Buy Rating on Cellectar Biosciences Backed by Strong Clinical Data and Promising Drug Pipeline

TipRanksMay 15 14:05 ET

Q1 2024 Cellectar Biosciences Inc Earnings Call

Yahoo FinanceMay 15 03:43 ET

Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Yahoo FinanceMay 15 03:02 ET

Earnings Call Summary | Cellectar BioSciences(CLRB.US) Q1 2024 Earnings Conference

The following is a summary of the Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript:Financial Performance:Cellectar Biosciences saw a significant increase in cash and cash equivalent

moomoo AIMay 14 13:47 ET · Conference Call

Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript

Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 14 13:05 ET

Express News | Cellectar Biosciences' Cash and Cash Equivalents, As of March 31, 2024, Was $40M That Is Expected To Provide Cash Runway Into Fourth Quarter Of 2024

BenzingaMay 14 06:48 ET

Express News | Cellectar Biosciences Inc - Qtrly Shr Loss $0.74

ReutersMay 14 06:41 ET

Express News | Cellectar Biosciences Inc - Believes Its Cash Balance as of March 31, 2024, Is Adequate to Fund Its Basic Budgeted Operations Into Q4 of 2024

ReutersMay 14 06:40 ET

Cellectar Biosciences 1Q Loss/Shr 74c >CLRB

Cellectar Biosciences 1Q Loss/Shr 74c >CLRB

Dow JonesMay 14 06:40 ET

Express News | Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update

ReutersMay 14 06:40 ET

Express News | Cellectar Biosciences Q1 2024 GAAP EPS $(0.74) Misses $(0.56) Estimate

BenzingaMay 14 06:34 ET

Cellectar BioSciences | 10-Q: Quarterly report

SEC announcementMay 14 06:34 ET · Announcements

Cellectar Biosciences Q1 2024 Earnings Preview

Seeking AlphaMay 13 13:37 ET

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day

FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercial

GlobeNewswireMay 8 06:40 ET

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024

FLORHAM PARK, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for

GlobeNewswireMay 7 06:40 ET

Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal

Seeking AlphaMay 2 14:31 ET

Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?

Yahoo FinanceMar 29 08:00 ET

Buy Rating on Cellectar Biosciences Backed by Promising Drug Candidate and Solid Financials

TipRanksMar 28 15:25 ET

Cellectar Biosciences Price Target Raised to $28.00/Share From $20.00 by Roth MKM

Cellectar Biosciences Price Target Raised to $28.00/Share From $20.00 by Roth MKM

Dow JonesMar 28 13:13 ET

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 28 10:33 ET